Vericel Corporation (VCEL) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
VCEL Revenue Growth
Revenue Breakdown (FY 2025)
VCEL's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
VCEL Revenue Analysis (2014–2025)
As of May 8, 2026, Vericel Corporation (VCEL) generated trailing twelve-month (TTM) revenue of $292.1 million, reflecting explosive growth of +30.1% year-over-year. The most recent quarter (Q1 2026) recorded $68.4 million in revenue, down 26.4% sequentially.
Looking at the longer-term picture, VCEL's 5-year compound annual growth rate (CAGR) stands at +17.3%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $276.3 million in 2025, representing a new all-time high.
Revenue diversification analysis shows VCEL's business is primarily driven by MACI Implants And Kits (100%). With over half of revenue concentrated in MACI Implants And Kits, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including MGTX (+96.8% YoY), FATE (-51.2% YoY), and AGIO (+78.3% YoY), VCEL has underperformed the peer group in terms of revenue growth. Compare VCEL vs MGTX →
VCEL Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| VCELCurrent | $292M | +30.1% | +17.3% | 4.0% | |
 MGTX | $33M | +96.8% | +20.1% | -493.4% | |
 FATE | $7M | -51.2% | -26.7% | -2222.4% | |
 AGIO | $54M | +78.3% | - | -873.9% | |
 NTLA | $68M | +16.9% | +3.1% | -651.7% |
VCEL Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $276.3M | +16.5% | $205.6M | 74.4% | $11.0M | 4.0% |
| 2024 | $237.2M | +20.1% | $172.1M | 72.6% | $4.5M | 1.9% |
| 2023 | $197.5M | +20.2% | $135.6M | 68.6% | $-6,464,000 | -3.3% |
| 2022 | $164.4M | +5.2% | $109.8M | 66.8% | $-17,058,000 | -10.4% |
| 2021 | $156.2M | +25.8% | $106.0M | 67.9% | $-7,854,000 | -5.0% |
| 2020 | $124.2M | +5.4% | $84.2M | 67.8% | $2.4M | 1.9% |
| 2019 | $117.8M | +29.7% | $80.3M | 68.1% | $-11,251,000 | -9.5% |
| 2018 | $90.9M | +42.1% | $58.7M | 64.6% | $-3,909,000 | -4.3% |
| 2017 | $63.9M | +17.5% | $33.6M | 52.5% | $-14,984,000 | -23.4% |
| 2016 | $54.4M | +6.3% | $26.1M | 47.9% | $-19,245,000 | -35.4% |
See VCEL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VCEL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare VCEL vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonVCEL — Frequently Asked Questions
Quick answers to the most common questions about buying VCEL stock.
Is VCEL's revenue growth accelerating or slowing?
VCEL revenue is accelerating at +30.1% year-over-year, exceeding the 5-year CAGR of +17.3%. TTM revenue reached $292M. Growth momentum has increased versus prior periods.
What is VCEL's long-term revenue growth rate?
Vericel Corporation's 5-year revenue CAGR of +17.3% reflects the sustained expansion pattern. Current YoY growth of +30.1% is above this long-term average.
How is VCEL's revenue distributed by segment?
VCEL reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.